Pharmaceutical and Medical Products Industry Practice
Our world and lives are changing. As the global community evolves, pharmaceuticals and medical products continue to make significant contributions to the global human condition, our quality of life, eco-responsibility, and sustainability. As pharmaceutical and medical products deliver life-changing innovation, global pricing pressures, and increased competition and regulation present real challenges for the industries.
We work with leading pharmaceutical and medical product manufacturers to create business value and deliver high impact results. Our experience in all aspects of pharmaceutical and medical product operations allows us to help clients identify opportunities for efficient transformation, revenue optimization and balanced cost reduction.
Customer Centricity, be passionate and truly put the customer comes first, commit to building relationships and be a brand that analyzes and plans.
Executives predict that it will take the biotech industry a decade before it achieves end-to-end continuous biomanufacturing. Learn how WGA can help today.
Big Data innovations in the pharmaceutical industry have the potential to revolutionize new life-saving drug development and patient outcomes.
Patient Centric and the Pharmaceutical Industry. What’s best for the brand may not be the best for the patient. Improving Patient outcomes.
WGA’s Pharmaceutical and Medical Product Expertise
We take a fully engaged approach to working with our pharmaceutical and medical product clients, with a focus on simple to execute and sustain strategies that result in direct financial impact.
Our Pharmaceutical and Medical Products Industry services include:
- Network Strategy
- Supply Chain Management
- Quality and Compliance
We analyze our client’s internal and external manufacturing, and supply chain networks to align corporate strategy, compliance, quality and cost with enduring results. We also help our clients balance production in lower cost countries with supply risks, optimize global manufacturing configurations, turnaround under-performing plants, assisting with plant closures or transfer of operations, products and technology.
We transform shopfloor efficiency through the use of world-class lean manufacturing tools and principles. We examine and benchmark industry standards (e.g. maintenance, facilities, cleaning standards, technologies, methods, practices, process), manufacturing costs and productivity profiles to industry competitors in the active pharmaceutical ingredients (API), biologics and product fill/finish industry segments.
Supply Chain Management
We focus on simplifying complexity, aggressively mitigating risk and security, eliminating waste, re-engineering distribution networks, lowering inventory levels, re-mediating backorders and sustain reliable supply.
Quality and Compliance
Our commitment to product safety, quality and compliance is at the core of our services. We help clients globally align quality standards and practices, reenforce a quality focused culture, improve risk management methods, and internalize quality and compliance in all aspects of operations to achieve a balanced compliance profile.
We help pharmaceutical and medical products companies address issues ranging from business unit strategy to overall corporate strategy. Among other topics, we can assist with mergers and acquisitions, including post-merger management, market entry and growth, business unit turnaround, and development of a new business.
Our pharmaceutical and medical products work focuses on four areas: product launch, marketing, sales, and market access. For instance, we can assist with pharmaceutical and medical products growth strategies, pricing, pharmaceutical and medical products market development, promotional campaigns, customer segmentation and targeting, pharmaceutical and medical products sales force effectiveness, and payor reimbursement. We also support clients in developing innovative commercial models and executing commercial strategies.
We support pharmaceutical and medical product businesses with all types of organizational challenges, including global expansion and entry into emerging markets. In addition to providing advice on structure and governance, we assist with issues related to a company’s culture and its overall “health,” such as mindset and behavior problems that hinder performance. We have experience with organizational issues in all departments, including medical, clinical, and regulatory.
Our pharmaceutical and medical products operations expertise covers six main areas: manufacturing, supply chain management, external supply, quality and compliance, network strategy, and product development and lifecycle strategy. For instance, we can help pharmaceutical and medical products clients apply lean process improvements to all operational areas, including manufacturing, finance, and back-office functions. We also frequently support pharmaceutical and medical product clients in investigating offshoring and outsourcing options, as well as possible partnerships with pharmaceutical and medical product contract manufacturing organizations (CMOs).
Pharmaceutical Best Practices: Benchmark and Recommended Current Practices (RCP)
WGA’s proprietary Recommended Current Practices (RCP) best practices benchmark standard is a collaboratively developed industry benchmark. RCP combines current pharmaceutical and medical product industry best practices with maturity models to score, rank and compare a broad array of specific manufacturing capabilities (e.g. leadership, manufacturing, planning, maintenance, equipment, engineering, facilities and cleaning).
RCP Asset Management Capability Example
This capability includes over 320+ recommended elements in maintenance, engineering and materials management
– Culture and Leadership
Lean Six Sigma Culture, Decision-making, tone from the top, leadership commitment and oversight
– Asset Care & Lifecycle
Preventative maintenance, failure rates and monitoring of facilities, utilities, environmental, tools and manufacturing equipment
– Personnel Qualification
Competency, proficiency and on-going talent development
– Materials Management
Reliability and management of spare parts, duplicate parts and materials
– Planning & Scheduling
Integrated coordination of preventative maintenance and the manufacturing production schedule
– Technical Information
Management of facilities, utilities, environmental, tools and manufacturing equipment technical and training materials
After we experienced a cluster of downtime events related to preventative maintenance issues at four of our sterile pharmaceutical manufacturing plants in North America and Puerto Rico, we needed a new operating model in our maintenance program. We engaged WGA to conduct an industry benchmark exercise of our maintenance program at each of our plants using their RCP™ benchmark method. They helped us identify several key gaps, develop a Maintenance Excellence strategy and manage the implementation of the strategyVice President Manufacturing$68B Diversified Pharmaceutical Manufacturer
WGA assisted us with developing and executing scenario-based turnaround strategies and addressing a number of business problems. WGA’s experience and services have helped us reduce operational costs, increase our competitiveness and improve operations.Sr. Director Manufacturing Operations$102B Pharmaceutical Manufacturer
WGA assisted us with developing and executing scenario-based turnaround strategies and addressing a number of business problems. WGA’s experience and services have helped us reduce operational costs, increase our competitiveness and improve operationsSr. Director Supply Chain Operations$276B Pharmaceutical, Consumer and Medical Device Manufacturer
After we had multiple supply disruptions and missed customer ship dates, we uncovered several weaknesses in our manufacturing network design. Though we were able to resolve some short term issues, it was clear we needed outside expertise. We originally asked a large consulting firm to develop a new design strategy but what we got was a generic solution. Frustrated with the outcome and service costs, I reached out to WGA to address our business problem. WGA not only optimized our network but redesigned our manufacturing site selection process to identify, assess and mitigate future supply and quality risksVice President Global Manufacturing Operations$107B Generic Pharmaceutical Manufacturer
Dramatic and sustainable pharmaceutical plant maintenance annual cost reductions with WGA’s Recommended Current Practices RCP Benchmark service.
Unnecessary supply disruptions caused by maintenance and spare part management failures resolved with Pharmaceutical Maintenance Excellence with WGA’s RCP
FDA regulatory maintenance findings threatens $2.3 Billion/year in pharmaceutical trade revenue. WGA’s RCP Pharmaceutical Maintenance benchmark case study